Pharma News - Chemdiv

Chinese scientists find a new target for gene therapy for osteoarthritis

BEIJING, April 2 (Xinhua) -- Chinese scientists have found a new therapeutic target for rejuvenating aging cells, shedding light on possible gene therapy for osteoarthritis.

Apexigen Announces New Clinical Data On APX005M In Combination Therapy For Pancreatic Cancer At The AACR Annual Meeting 2019

SAN CARLOS, Calif.

$Phase 3 ADMIRAL Trial Data Show XOSPATA® (gilteritinib) Significantly Prolongs Overall Survival in Adult Patients with FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia Compared with Salvage Chemotherapy$

Phase 3 ADMIRAL Trial Data Show XOSPATA® (gilteritinib) Significantly Prolongs Overall Survival in Adult Patients with FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia Compared with Salvage Chemotherapy

TOKYO, April 1, 2019 /PRNewswire/ -- Astellas Pharma Inc.

Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe

LOS ANGELES & CASTRES, France--(BUSINESS WIRE)--Puma Biotechnology, Inc.

FDA warns homeopathic firms for putting patients at risk with significant violations of manufacturing quality standards

The U.

Cholera kills two, infects 1,400 in cyclone-hit Mozambique

A cyclone-induced cholera outbreak in central Mozambique has killed two people and infected more than 1,400, the government announced Tuesday on the eve of the launch of a mass vaccination drive.

Vitamins, carotenoids associated with lower risk for cataract

(HealthDay)—Higher consumption of certain vitamins and carotenoids is associated with a significantly decreased risk for age-related cataract (ARC) in cohort studies, according to a ...

Depression, obesity, chronic pain could be treated by targeting the same key protein

Major depression, obesity, and chronic pain are all linked to the effects of one protein, called “FK506-binding protein 51,” or FKBP51.

Next-generation single-dose antidotes for opioid overdoses

The U.

Party drug linked to new treatment for sleep disorder

A new innovative approach is being tested to treat people with a severe sleep disorder called narcolepsy.

Gilteritinib improves survival for patients with acute myeloid leukemia

Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for patients with relapsed or refractory acute myeloid leukemia (AML) harboring a FLT3 mutation co...

The state of New York accuses six pharmaceutical companies in the fraudulent marketing of opioid analgesics

The New York Attorney General is suing OxyContin maker Purdue Pharma, Johnson & Johnson, McKesson Corp.